WHO backs trials of two Ebola vaccines as DRC outbreak continues

10 SOURCES DEMOCRATIC REPUBLIC OF THE CONGOUPDATED

NOT MEDICAL ADVICE

This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.

BLUF

The WHO has backed trials of two vaccines targeting the Bundibugyo Ebola strain, for which there is no approved vaccine. Separately, a British health worker with Ebola is being evacuated from the DRC to the UK; two people isolated in Israel after returning from the DRC tested negative.

HOW THIS BRIEF WAS MADE 7 outlets: 6 international · 1 specialist. Automated sourcing and summaries by the BLUF engine. Corrections

Why it matters

The outbreak and vaccine research affect public health in the DRC and countries reporting spread or suspected cases. The supplied reports do not identify a direct U.S. consequence.

What happens next

The vaccine candidates must be evaluated in trials; the reports do not give a timetable for results. The British patient was expected to arrive in the UK on Wednesday or Thursday, according to a document cited by Reuters.

Progress and findings from the vaccine trials

The British patient’s transfer and condition

Whether new Ebola cases are reported outside the DRC